7Baggers
 Liquidity Mapping Around (CNTA) Price Events  news.stocktradersdaily.com Sun, 16 Nov 2025 11:22:02 GMT
 catalyst-driven week in venture and public equity: finance report  BioCentury Sat, 15 Nov 2025 01:23:00 GMT
 Centessa Pharma chief technology officer sells $1.04 million in shares  Investing.com Thu, 13 Nov 2025 22:23:42 GMT
 CNTA: Wells Fargo Increases Price Target to $35 | CNTA Stock New  GuruFocus Thu, 13 Nov 2025 16:57:15 GMT
 Why Centessa Pharmaceuticals Stock Crushed the Market Today  sharewise.com Thu, 13 Nov 2025 02:47:12 GMT
 Why Centessa Pharmaceuticals Stock Crushed the Market Today  The Motley Fool Wed, 12 Nov 2025 23:27:00 GMT
 Centessa Pharmaceuticals Shares Surge Amid Positive Outlook  TipRanks Wed, 12 Nov 2025 18:11:56 GMT
 Centessa Pharmaceuticals stock hits 52-week high at $25.44  Investing.com Wed, 12 Nov 2025 15:28:02 GMT
 Alkermes races to phase 3 after posting another narcolepsy win  Fierce Biotech Wed, 12 Nov 2025 14:30:20 GMT
 centessa pharma drops on $250 mln share sale  TradingView Wed, 12 Nov 2025 13:15:55 GMT
 Centessa Pharmaceuticals launches public offering of ADSs By Investing.com  Investing.com Nigeria Wed, 12 Nov 2025 08:23:06 GMT
 Centessa prices public offering of 11.6 million ADSs at $21.50 each  Investing.com Nigeria Wed, 12 Nov 2025 07:24:35 GMT
 centessa pharmaceuticals plc  Via Ritzau Wed, 12 Nov 2025 01:40:00 GMT
 Centessa Pharmaceuticals stock falls after announcing public offering  Investing.com Wed, 12 Nov 2025 01:17:44 GMT
 Centessa Pharma slips after launching share offering  TradingView Tue, 11 Nov 2025 21:15:14 GMT
 Centessa Pharmaceuticals launches public offering of ADSs  Investing.com Tue, 11 Nov 2025 21:14:21 GMT
 centessa pharmaceuticals plc  Via Ritzau Tue, 11 Nov 2025 21:00:00 GMT
 Staying awake: OXR2 agonists compete in narcolepsy  biocentury.com Fri, 07 Nov 2025 19:32:00 GMT
 Centessa’s Sleep Disorder Drug Shows Broad Potential But Faces Tough Competition  Citeline News & Insights Fri, 07 Nov 2025 12:39:34 GMT
 Why Centessa Pharmaceuticals Shares Are Under Pressure  TipRanks Fri, 07 Nov 2025 11:22:26 GMT
 centessa pharmaceuticals advances ox2r agonist program  TipRanks Fri, 07 Nov 2025 06:55:58 GMT
 Centessa’s stock recovers from drop on sleep drug data  Clinical Trials Arena Thu, 06 Nov 2025 08:00:00 GMT
 Centessa Pharmaceuticals Advances OX2R Agonist Program  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Centessa touts OX2R agonist data in broad narcolepsy trial  BioWorld MedTech Wed, 05 Nov 2025 15:00:00 GMT
 centessa pharmaceuticals plc  Via Ritzau Wed, 05 Nov 2025 12:00:00 GMT
 why (cnta) price action is critical for tactical trading  news.stocktradersdaily.com Wed, 05 Nov 2025 10:06:04 GMT
 Centessa Pharmaceuticals Reports Q3 2025 Financial Results  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 centessa pharmaceuticals stock hits 52-week high at 25.35 usd by investing.com  Investing.com Australia Tue, 04 Nov 2025 08:00:00 GMT
 Centessa Pharmaceuticals stock hits 52-week high at 25.35 USD  Investing.com Mon, 03 Nov 2025 08:00:00 GMT
 stephens initiates centessa pharmaceuticals at overweight  MarketScreener Tue, 28 Oct 2025 07:00:00 GMT
 centessa initiated with an overweight at stephens  TipRanks Tue, 28 Oct 2025 07:00:00 GMT
 centessa pharma (cnta) president sells $200k in shares by investing.com  Investing.com South Africa Tue, 28 Oct 2025 03:32:54 GMT
 centessa pharmaceuticals executive sells 8,000 shares  TradingView Tue, 28 Oct 2025 00:00:00 GMT
 centessa pharmaceuticals (nasdaq:cnta) upgraded at wall street zen  MarketBeat Mon, 27 Oct 2025 07:00:00 GMT
 centessa pharma (cnta) president sells $200k in shares  Investing.com Mon, 27 Oct 2025 07:00:00 GMT
 centessa pharmaceuticals stock hits 52-week high at $24.65 by investing.com  Investing.com Philippines Sat, 25 Oct 2025 01:05:44 GMT
 Centessa Pharmaceuticals stock hits 52-week high at $24.65  Investing.com Fri, 24 Oct 2025 07:00:00 GMT
 understanding momentum shifts in (cnta)  news.stocktradersdaily.com Fri, 17 Oct 2025 08:00:02 GMT

Centessa Pharmaceuticals plc
(NASDAQ:CNTA) 

CNTA stock logo

Centessa Pharmaceuticals plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams.

Founded: 2020
CEO: Saurabh Saha  
Sector:
Industry:

Share this website to your friends